Insight Pharmaceuticals Recalls One Lot of Nostrilla Nasal Decongestant Spray Due to Bacteria

Advertisement

Insight Pharmaceuticals in Langhorne, Pa., has issued a recall of its Nostrilla Nasal Decongestant nasal spray following internal investigations that determined the potential presence of a microbial contaminant.

Read the full report in Becker’s ASC Review on Insight Pharmaceuticals.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.